RPL3 and colorectal carcinoma: To evaluate if uL3 expression may influence the CRC patient’soutcome, we analyzed a cohort of 594 colorectal patients (TCGA datasets, https://www.cbioportal.org/)35 and divided them into uL3 high- anduL3 low-expression groups (median split).